Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial.
about
Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Use of thienopyridine prior to ...... nsights from the TRACER trial.
@en
type
label
Use of thienopyridine prior to ...... nsights from the TRACER trial.
@en
prefLabel
Use of thienopyridine prior to ...... nsights from the TRACER trial.
@en
P2093
P2860
P50
P356
P1476
Use of thienopyridine prior to ...... nsights from the TRACER trial.
@en
P2093
Frans Van de Werf
Giuseppe Ambrosio
Harvey D White
John Strony
Paul W Armstrong
Philip E Aylward
Ralf E Harskamp
Robert M Clare
P2860
P304
P356
10.1177/2048872616633880
P50
P577
2016-02-19T00:00:00Z